Lorraine Registry of Multiple Sclerosis

Recruiting Observational Study
Multiple Sclerosis
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
6,000 (estimated)
Sponsor
Central Hospital, Nancy, France · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The RelSEP aims to register exhaustively every new case of multiple sclerosis (MS) occuring in Lorraine a French region, and follow up on them for an indefinite duration, registering disease evolution and intercurrent events.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Having a confirmed multiple sclerosis diagnosis * Living in Lorraine (French region) Exclusion Criteria: * Refusal to be registered
Contacts

Francis Guillemin, MD, PHD

francis.guillemin@chru-nancy.fr

CONTACT

Jonathan Epstein, MD, MSc

j.epstein@chru-nancy.fr

CONTACT